Abstract

HPR28 Last Resort for Reimbursement of New Drugs in Germany: When the Arbitration Office Must Decide

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call